A First Look at the Numbers A 2026 study published in The Lancet Obstetrics, Gynaecology, and Women's Health took a direct look at this question, evaluating 120 postmenopausal women treated with tirzepatide, one of the most effective GLP-1 and GIP dual receptor agonists currently available [16]
Carmot Therapeutics experimental dual agonist, CT-868, is currently in phase 2 trials for diabetes
Hydroxocobalamin is an inactive form of B12 which needs to be metabolised to either methylcobalamin or adenosylcobalamin and therefore tends to last longer in the body due to this conversion taking some time
Timing plays a key role in how effectively L-Carnitine supports fat loss
Pharmaceutical medications such as semaglutide-based drugs mimic this hormone and are commonly prescribed for obesity or type 2 diabetes
Ipamorelin probes the ghrelin / GHS-R1a axis : a separate pathway, notable in its original characterisation for releasing GH without the ACTH and cortisol rise seen with earlier secretagogues